MLTX
Price
$41.97
Change
-$0.66 (-1.55%)
Updated
May 9, 6:59 PM EST
90 days until earnings call
ORIC
Price
$9.50
Change
-$0.10 (-1.04%)
Updated
May 9, 6:59 PM EST
90 days until earnings call
Ad is loading...

MLTX vs ORIC

Header iconMLTX vs ORIC Comparison
Open Charts MLTX vs ORICBanner chart's image
MoonLake Immunotherapeutics
Price$41.97
Change-$0.66 (-1.55%)
Volume$68.25K
CapitalizationN/A
Oric Pharmaceuticals
Price$9.50
Change-$0.10 (-1.04%)
Volume$203.63K
CapitalizationN/A
View a ticker or compare two or three
MLTX vs ORIC Comparison Chart

Loading...

MLTXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
ORICDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
MLTX vs. ORIC commentary
May 10, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLTX is a StrongBuy and ORIC is a Hold.

COMPARISON
Comparison
May 10, 2024
Stock price -- (MLTX: $41.97 vs. ORIC: $9.51)
Brand notoriety: MLTX and ORIC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MLTX: 33% vs. ORIC: 51%
Market capitalization -- MLTX: $2.64B vs. ORIC: $647.25M
MLTX [@Biotechnology] is valued at $2.64B. ORIC’s [@Biotechnology] market capitalization is $647.25M. The market cap for tickers in the [@Biotechnology] industry ranges from $567.57B to $0. The average market capitalization across the [@Biotechnology] industry is $2.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLTX’s FA Score shows that 0 FA rating(s) are green whileORIC’s FA Score has 1 green FA rating(s).

  • MLTX’s FA Score: 0 green, 5 red.
  • ORIC’s FA Score: 1 green, 4 red.
According to our system of comparison, ORIC is a better buy in the long-term than MLTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLTX’s TA Score shows that 2 TA indicator(s) are bullish while ORIC’s TA Score has 5 bullish TA indicator(s).

  • MLTX’s TA Score: 2 bullish, 6 bearish.
  • ORIC’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ORIC is a better buy in the short-term than MLTX.

Price Growth

MLTX (@Biotechnology) experienced а -1.41% price change this week, while ORIC (@Biotechnology) price change was -0.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.16%. For the same industry, the average monthly price growth was -4.80%, and the average quarterly price growth was +70.58%.

Reported Earning Dates

MLTX is expected to report earnings on Aug 08, 2024.

ORIC is expected to report earnings on Aug 08, 2024.

Industries' Descriptions

@Biotechnology (+0.16% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for MLTX with price predictions.
OPEN
A.I.dvisor published
a Summary for ORIC with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
MLTX($2.64B) has a higher market cap than ORIC($647M). ORIC YTD gains are higher at: 3.370 vs. MLTX (-30.502).
MLTXORICMLTX / ORIC
Capitalization2.64B647M408%
EBITDAN/AN/A-
Gain YTD-30.5023.370-905%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
MLTXORIC
RSI
ODDS (%)
Bullish Trend 1 day ago
50%
Bullish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
55%
Bearish Trend 1 day ago
85%
Momentum
ODDS (%)
Bearish Trend 1 day ago
43%
Bullish Trend 1 day ago
82%
MACD
ODDS (%)
Bullish Trend 1 day ago
59%
Bullish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
52%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
46%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
N/A
Bullish Trend 7 days ago
83%
Declines
ODDS (%)
Bearish Trend 1 day ago
60%
Bearish Trend 1 day ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
63%
Bullish Trend 1 day ago
84%
Aroon
ODDS (%)
Bearish Trend 1 day ago
36%
Bearish Trend 1 day ago
86%
View a ticker or compare two or three
Ad is loading...
MLTXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
ORICDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HFCIX45.490.78
+1.74%
Hennessy Focus Institutional
EIPDX16.960.14
+0.83%
Parametric Dividend Income I
DFUEX25.790.17
+0.66%
DFA US Social Core Equity 2 Portfolio
JNBZX9.710.04
+0.41%
JPMorgan Income Builder R6
WRAIX12.82N/A
N/A
Wilmington Global Alpha Equities I

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been loosely correlated with SYRE. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if MLTX jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
-1.55%
SYRE - MLTX
41%
Loosely correlated
+6.57%
BCYC - MLTX
39%
Loosely correlated
-0.25%
ORIC - MLTX
32%
Poorly correlated
-0.94%
BNTC - MLTX
31%
Poorly correlated
+5.90%
PHVS - MLTX
30%
Poorly correlated
-1.34%
More

ORIC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORIC has been loosely correlated with MDGL. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ORIC jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORIC
1D Price
Change %
ORIC100%
-0.94%
MDGL - ORIC
34%
Loosely correlated
-0.43%
CMPX - ORIC
33%
Loosely correlated
+0.63%
PTGX - ORIC
33%
Loosely correlated
+4.43%
ARVN - ORIC
33%
Loosely correlated
-1.30%
NTLA - ORIC
33%
Loosely correlated
+8.13%
More